(Fool.com) Paulson & Co., an event-driven arbitrage fund, gobbled up Teva Pharmaceutical Industries stock in the third quarter. Should average investors follow their lead? According to the third-quarter 13F filings with the SEC, Paulson & Co., a $20 billion hedge fund headed by noted investor John Paulson, raised its stake in generic-drug maker Teva Pharmaceutical Industries (NYSE:TEVA) by an astounding 786%. With a value of around $1 billion, Teva was the company’s largest holding at the end of the three-month period…..
This $20 Billion Hedge Fund Is Gobbling Up Teva Pharmaceutical Industries Limited
This entry was posted in Syndicated. Bookmark the permalink.
